Altogether, glycolytic reprogramming in macrophages underlies the initiation, exacerbation and infection-complicated phases of asthma, providing both the energetic supply and signaling framework for inflammation and offering therapeutic nodes such as glycolytic blockade or inhibition of HIF-1α and PKM2. The gene discussed is HIF1A; the disease is asthma.